A 39 amino acid fragment of the cell cycle regulator p21 is sufficient to bind PCNA and partially inhibit DNA replication in vivo - PubMed (original) (raw)

A 39 amino acid fragment of the cell cycle regulator p21 is sufficient to bind PCNA and partially inhibit DNA replication in vivo

J Chen et al. Nucleic Acids Res. 1996.

Abstract

The cell cycle regulator p21 interacts with and inhibits the DNA replication and repair factor proliferating cell nuclear antigen (PCNA). We have defined a 39 amino acid fragment of p21 which is sufficient to bind PCNA with high affinity (Kd 10-20 nM). This peptide can inhibit DNA replication in vitro and microinjection of a GST fusion protein containing this domain inhibited S phase in vivo. Despite its high affinity for PCNA, the free 39 amino acid peptide does not have a well-defined structure, as judged from circular dichroism and nuclear magnetic resonance measurements, suggesting an induced fit mechanism for the PCNA-p21 interaction. The association of the small peptide with PCNA was thermolabile, suggesting that portions of p21 adjoining the minimal region of contact stabilize the interaction. In addition, a domain containing 67 amino acids from the N-terminus of PCNA was defined as both necessary and sufficient for binding to p21.

PubMed Disclaimer

Cited by

Destabilization of the PCNA trimer mediated by its interaction with the NEIL1 DNA glycosylase.
Prakash A, Moharana K, Wallace SS, Doublié S. Prakash A, et al. Nucleic Acids Res. 2017 Mar 17;45(5):2897-2909. doi: 10.1093/nar/gkw1282. Nucleic Acids Res. 2017. PMID: 27994037 Free PMC article.
Cytoplasmic p21 induced by p65 prevents doxorubicin-induced cell death in pancreatic carcinoma cell line.
Zhou Y, Li G, Ji Y, Liu C, Zhu J, Lu Y. Zhou Y, et al. J Biomed Sci. 2012 Feb 4;19(1):15. doi: 10.1186/1423-0127-19-15. J Biomed Sci. 2012. PMID: 22305266 Free PMC article.
Proliferating Cell Nuclear Antigen in the Era of Oncolytic Virotherapy.
Kwan A, Mcdermott-Brown I, Muthana M. Kwan A, et al. Viruses. 2024 Aug 7;16(8):1264. doi: 10.3390/v16081264. Viruses. 2024. PMID: 39205238 Free PMC article. Review.
The potential of PCNA inhibition as a therapeutic strategy in cervical cancer.
Wendel SO, Snow JA, Gu L, Banerjee NS, Malkas L, Wallace NA. Wendel SO, et al. J Med Virol. 2023 Nov;95(11):e29244. doi: 10.1002/jmv.29244. J Med Virol. 2023. PMID: 38010649 Free PMC article. Review.
Efficient parvovirus replication requires CRL4Cdt2-targeted depletion of p21 to prevent its inhibitory interaction with PCNA.
Adeyemi RO, Fuller MS, Pintel DJ. Adeyemi RO, et al. PLoS Pathog. 2014 Apr 3;10(4):e1004055. doi: 10.1371/journal.ppat.1004055. eCollection 2014 Apr. PLoS Pathog. 2014. PMID: 24699724 Free PMC article.

References

1. Curr Biol. 1994 Dec 1;4(12):1062-8 - PubMed
1. Nature. 1995 Mar 23;374(6520):386-8 - PubMed
1. Curr Biol. 1995 Mar 1;5(3):275-82 - PubMed
1. Oncogene. 1995 Jun 15;10(12):2281-7 - PubMed
1. Biochemistry. 1995 Jul 11;34(27):8869-75 - PubMed

A 39 amino acid fragment of the cell cycle regulator p21 is sufficient to bind PCNA and partially inhibit DNA replication in vivo - PubMed (original) (raw)